Analytical Data
-
Gene name
MYOM2
- Application
-
Alternative Names
TTNAP; Myomesin family member 2; 165 kDa titin-associated protein; 165 kDa connectin-associated protein
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P54296
-
Expression Region
Pro1130~Ser1434
-
Molecular Weight
38kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MYOM2, a member of the myomesin family of proteins, plays a crucial role in the structure and function of skeletal muscle. Research into MYOM2 recombinant protein has gained interest due to its potential implications in muscle development, repair, and various myopathies. MYOM2 is primarily located in the M-line of the sarcomere, where it contributes to the assembly and stability of the thick filament structure, thereby influencing muscle contraction and overall muscle integrity. Studies have suggested that mutations or dysregulation of MYOM2 may be associated with specific muscle disorders, highlighting the importance of understanding its biochemical properties and interactions. Recombinant MYOM2 protein offers a valuable tool for investigating these aspects, allowing researchers to analyze its functional characteristics in vitro and in vivo. By exploring the role of MYOM2 in muscle physiology and pathophysiology, scientists aim to uncover novel therapeutic targets and strategies for treating muscle-related diseases.
